《Correction to “”Modular, Step-Efficient Palladium-Catalyzed Cross-Coupling Strategy To Access C6-Heteroaryl 2-Aminopurine Ribonucleosides”” [Erratum to document cited in CA167:176274]》 was written by Buchanan, Helena S.; Pauff, Steven M.; Kosmidis, Tilemachos D.; Taladriz-Sender, Andrea; Rutherford, Olivia I.; Hatit, Marine Z. C.; Fenner, Sabine; Watson, Allan J. B.; Burley, Glenn A.. Related Products of 847818-74-0This research focused ontriazole isoxazole isonitrile nucleoside preparation cycloaddition erratum; aminopurine nucleoside chloroguanosine Suzuki Miyaura chloroguanosine heteroarylaminopurine Sonogashira coupling; palladium catalyzed coupling heteroaryl aminopurine nucleoside cycloaddition isonitrile isoxazole; erratum. The article conveys some information:
The following statement was inadvertently omitted from the Acknowledgments section of the manuscript: “”This work was supported by an EPSRC-GSK industrial CASE studentship for H.S.B. In the experiment, the researchers used many compounds, for example, 1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole(cas: 847818-74-0Related Products of 847818-74-0)
1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole(cas: 847818-74-0) belongs to pyrazoles. Pyrazoles are commonly used scaffold molecules in drug discovery projects. The use of pyrazole derivatives is based on their analgesic, monoamine oxidase inhibitory, anti-inflammatory, antipyretic, neuroleptic, anticonvulsant, antiarrhythmic, sedative, muscle relaxant, antidiabetic and antibacterial activities. Related Products of 847818-74-0
Referemce:
Pyrazole – Wikipedia,
Pyrazoles – an overview | ScienceDirect Topics